Cytotoxicity and in vivo biosafety of the polylactide based bone composite materials
Macromolecular Research(2017)
摘要
In this study, we investigated the in vitro cytotoxicity and in vivo biosafety of reinforced polylactide (PLA) composites with hyaluronic acid-chitosan (HACS) complex and β -tricalcium phosphate ( β -TCP) powder. The cytotoxicity of HACS/PLA (with β -TCP) composites was almost the same as that of neat PLA indicating that HACS/PLA (with β -TCP) composites did not have toxic effects. In in vivo biosafety tests using X-ray and micro-CT imaging, HACS/PLA (with β -TCP) composites did not show any fracture during 20 weeks of implantation in the tibia and femur of rabbits. The HACS/PLA (with β -TCP) composites did not induce severe inflammatory responses such as recruitment of macrophages around the implantation site, as assessed by H&E and immune staining of biopsy samples, for 6 weeks after insertion into SD rats. Addition of β -TCP powder to HACS/PLA composite enhanced bone induction and regeneration. The HACS/PLA composites prepared in the present study have potential maxillofacial and orthopedic applications.
更多查看译文
关键词
hyaluronic acid,chitosan,β-tricalcium phosphate,reinforced polylactide,in vivo evaluation,bone regeneration,bone fixation
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要